Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca

Contributed by: Business Wire

Logo

Tags

Research

General Health

Pharmaceutical

Oncology

Data Management

Technology

Artificial Intelligence

Health Technology

Science

Biotechnology

Other Science

Health

Biological Artificial Superintelligence

More Like This

ACCESS Newswire associated0

Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models

Owkin Announces Availability of K Pro in the AWS Marketplace SaaS Category

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences.

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

K Navigator home screen.

Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x

Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA.

Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA